UK shareholder meetings calendar - next 7 days Read More
EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits Read More
TRADING UPDATES: Keystone Law and Checkit post annual revenue growth Read More
AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb Read More
No Conditional US Approval So Far For ImmuPharma Lupus Drug Lupuzor Read More
UK TRADING UPDATE SUMMARY: Gore Street Energy Energises Drumkee Read More
IN BRIEF: Immupharma Says L1 Capital Converts USD200,000 Of Security Read More
ImmuPharma Partner To Discuss Progression Of Lupuzor Drug With US FDA Read More
UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter Read More
UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise Read More
IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4% Read More
IN BRIEF: Immupharma Repays Lind Global Convertible Security Read More
IN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission Read More
Immupharma Raises GBP6.5 Million In Oversubscribed Placing Read More
IN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
Immupharma Gets Over USD6 Million Investment From US Healthcare Funds Read More
UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand Read More
ImmuPharma Annual Loss Narrows; Plans "Optimised" Lupuzor Trial Read More
ImmuPharma Raises GBP1.5 Million Through Share Issue To Fund Expansion Read More
